PCDH9, protocadherin 9, 5101

N. diseases: 35; N. variants: 14
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.130 GeneticVariation disease GWASCAT Genome-Wide Association Study Identifies a Genetic Prediction Model for Postoperative Survival in Patients with Hepatocellular Carcinoma. 30945699 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.130 GeneticVariation disease GWASCAT Genomewide association study for C-reactive protein in Indians replicates known associations of common variants. 30945673 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.130 Biomarker disease BEFREE Salivary lnc-PCDH9-13:1 is a desirable biomarker for early HCC. 30045829 2018
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.130 PosttranslationalModification disease BEFREE Methylation of the PCDH9 promoter was observed in 22% primary HCC tissues (24/111 tumors). 28791409 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.130 AlteredExpression disease BEFREE We identified PCDH9 as a novel regulator of EMT by increasing the activity of GSK-3β and inhibiting Snail1, indicating its potential therapeutic value for reducing metastasis of HCC. 25172662 2014